The pooled HR indicated that positive/high expression of tissue VEGF had an obvious association with DFS in patients with ovarian cancer (HR 3.49, 95% CI 1.27–9.56;P=0.02) (Figure 4). Here, VEGFA is linked to ovarian carcinoma.